Pathological Hepatic Contrast-Enhanced Ultrasound (CEUS) Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation (allo-SCT)
Conclusion:Patients undergoing allo-SCT frequently show a pathological hepatic CEUS pattern, which can be quantified by OD measurement and is suggestive of preclinical VOD or yet undefined hepatic pathologies. Further studies to evaluate the clinical significance of a PE with regard to VOD development and risk of GvHD are ongoing.Figure 1.DisclosuresBurchert: Pfizer: Honoraria; Bayer: Research Funding; Bristol Myers Squibb: Honoraria, Research Funding; AOP Orphan: Honoraria, Research Funding; Novartis: Research Funding. Görg: Bracco imaging: Other: Bracco imaging supports workshop for contrast enhanced ultrasound for education at the university hospital in Marburg.
Source: Blood - Category: Hematology Authors: Trenker, C., Burchert, A., Michel, C. S., Schuhmacher, C., Schafer, J. A., Dohse, M., Neubauer, A., Sohlbach, K., Gorg, C. Tags: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II Source Type: research
More News: Bilirubin | Bone Marrow Transplant | Chemistry | Education | Hepatomegaly | Liver | Liver Transplant | Marburg Virus | Pain | Perfusion | Pfizer | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplant Surgery | Transplants | Ultrasound | Universities & Medical Training | Urology & Nephrology | Workshops